Elevated Myoglobin in Patients With Primary Aldosteronism: A Cross-Sectional Study.
Kang B, Peng C, Wang K, Song Y, Yang Y, Ma L, Mei M, Hu J, Yang S, Wu FF, Li Q.
Front Endocrinol (Lausanne). 2022 Feb 21;13:799174. doi: 10.3389/fendo.2022.799174. eCollection 2022.
Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk.
Katabami T, Matsuba R, Kobayashi H, Nakagawa T, Kurihara I, Ichijo T, Tsuiki M, Wada N, Ogawa Y, Sone M, Inagaki N, Yoshimoto T, Takahashi K, Yamamoto K, Izawa S, Kakutani M, Tanabe A, Naruse M.
Eur J Endocrinol. 2022 Apr 25;186(6):645-655. doi: 10.1530/EJE-21-1131.
Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD.
Chuang MH, Wang HY, Kan WC, Chien CC, Jiang MY, Huang YT, Wu VC, Chen JY.
Nephrol Dial Transplant. 2025 Sep 29;40(10):1897-1905. doi: 10.1093/ndt/gfaf064.
Primary Aldosteronism Influences Cardiac Structure, Function, and Disease Risk: Evidence From Mendelian Randomization Analysis.
Shen R, Pan C, Yu J, Dong C, Li Z, Zhang J, Dong Q, Yu K, Zeng Q.
J Clin Hypertens (Greenwich). 2024 Nov;26(11):1301-1309. doi: 10.1111/jch.14912. Epub 2024 Oct 7.
High plasma aldosterone concentration is associated with worse 24-h ambulatory blood pressure profile in patients with primary aldosteronism.
Morita R, Azushima K, Sunohara S, Haze T, Kobayashi R, Kinguchi S, Kanaoka T, Kobayashi K, Toya Y, Wakui H, Tamura K.
Hypertens Res. 2023 Aug;46(8):1995-2004. doi: 10.1038/s41440-023-01325-8. Epub 2023 May 30.
[Multiple intracerebral microhemorrhages associated with primary aldosteronism: a case report].
Miyata K, Imaizumi T, Horita Y, Hashimoto Y, Tanno K, Koide A, Niwa J.
No Shinkei Geka. 2003 Nov;31(11):1223-7.
Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.
Santana LS, Guimaraes AG, Almeida MQ.
Front Endocrinol (Lausanne). 2022 Jun 23;13:927669. doi: 10.3389/fendo.2022.927669. eCollection 2022.
Comparison of ambulatory blood pressure between patients with primary aldosteronism and other forms of hypertension.
Libianto R, Menezes S, Kaur A, Gwini SM, Shen J, Narayan O, Fuller PJ, Yang J, Young MJ.
Clin Endocrinol (Oxf). 2021 Mar;94(3):353-360. doi: 10.1111/cen.14373. Epub 2020 Dec 3.
Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism.
Obara T, Ito Y, Okamoto T, Kanaji Y, Yamashita T, Aiba M, Fujimoto Y.
Surgery. 1992 Dec;112(6):987-93.
[Case of ruptured multiple cerebral aneurysms associated with primary aldosteronism].
Sawada K, Maehara T, Inaji M, Toriyama H, Okada T, Nariai T, Aoyagi M, Doi M, Ohno K.
No Shinkei Geka. 2010 Apr;38(4):347-51.
